Researchers redefine hip arthroscopy with breakthrough surgical device
November 12, 2025
There’s a new tool in the hands of surgeons making waves in the world of hip arthroscopy.
There’s a new tool in the hands of surgeons making waves in the world of hip arthroscopy.
DALLAS, Nov. 6, 2025 /PRNewswire/ — Dallas-based MedCAD has been awarded 510(k) FDA clearance for its AccuStride fixation plates, part of a patient-specific solution available to surgeons as a complete foot and ankle (F&A) system. The company received 510(k) FDA clearance for its foot and ankle guides and planning system in March 2025. The AccuStride implant and surgical guide system coupled with the company’s proprietary planning software will enable foot and ankle surgeons to correct multiple related pathologies in a single procedure.
Microbot Medical (Nasdaq:MBOT) announced today that it began the U.S. commercial launch of its Liberty endovascular surgical robot.
ORLANDO, Fla., Oct. 29, 2025 /PRNewswire/ — Optimotion Implants, a medical device company that designs and manufactures total knee replacement implants and associated surgical instrumentation is expanding operations in the Tampa Bay area. Optimotion Implants is the only company in the world utilizing the revolutionary Lateral Approach technique in total knee replacement. Participating surgeons are highly trained on the Lateral Approach which allows them to do what others cannot, leading to better outcomes for patients.
Zimmer Biomet (NYSE: ZBH)+
announced today that it received FDA breakthrough device designation for its iodine-treated total hip replacement system.
PARSIPPANY, N.J., Oct. 21, 2025 /PRNewswire/ — Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, announced that it has recently received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ELEOS Proximal Tibia with NanoCept Antibacterial Technology. This marks the first 510(k) clearance for the NanoCept Antibacterial Technology since the original De Novo authorization was granted in April of 2024.
NextBiomedical this week announced it enrolled the first patient in its U.S. pivotal clinical trial evaluating its Nexsphere-F, a fast-resorbable microsphere for embolization treatment of musculoskeletal pain.
Globus Medical has launched the Anthem Elbow Fracture System, a plating system designed to help surgeons manage a wide range of elbow fractures with simplified workflow and flexible fixation options.
WEST CHESTER, Pa., Oct. 14, 2025 /PRNewswire/ — Centinel Spine®, LLC (“the Company”), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for 2-level indications for the prodiscC Vivo and prodisc C SK Cervical TDR devices. Since receiving FDA approval for 1-level indications in July 2022, nearly 20,000 prodiscC Vivo and prodisc C SK spinal levels have been implanted in the U.S. by over 1,100 surgeons.
OrthoIndy spine surgeon Dr Greg Poulter performed the inaugural SyncAR Spine case.